Ginkgo Bioworks Holdings, Inc. (DNA)

NYSE: DNA · Real-Time Price · USD

6.79

-0.45 (-6.22%)

At close: Aug 14, 2026, 4:00 PM EDT

6.82

+0.03 (0.44%)

After-hours: Aug 14, 2026, 7:59 PM EDT

Ginkgo Bioworks Holdings Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	84.54	167.2	561.57	944.07	1,316	1,550
Short-Term Investments	217.63	255.42	-	-	-	-
Cash & Short-Term Investments	302.16	422.62	561.57	944.07	1,316	1,550
Cash Growth	-36.21%	-24.74%	-40.52%	-28.25%	-15.11%	307.04%
Accounts Receivable	13.01	24.26	22.44	17.9	82.47	136.14
Other Receivables	-	-	-	-	1.56	-
Receivables	13.01	24.26	22.44	30.19	84.03	147.7
Inventory	-	-	-	-	4.36	3.51
Prepaid Expenses	14.44	17.93	12.89	22.7	35.11	18.94
Restricted Cash	2.92	7.03	5.84	4.79	8.22	-
Other Current Assets	-	-	-	-	2.57	2.9
Total Current Assets	332.54	471.84	602.74	1,002	1,450	1,723
Property, Plant & Equipment	504.85	528.7	598.16	394.99	718.79	145.77
Long-Term Investments	22.39	15.07	48.7	78.57	113.73	115.23
Goodwill	-	-	-	49.24	60.21	21.31
Other Intangible Assets	44.39	56.92	72.51	82.74	111.04	21.64
Other Long-Term Assets	85.89	40.04	41.17	44.45	47.81	43.99
Total Assets	990.05	1,120	1,377	1,665	2,539	2,071

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Accounts Payable	9.58	10.57	14.17	9.32	10.45	8.19
Accrued Expenses	44.51	15.57	19.19	49.87	52.3	85.14
Current Portion of Leases	-	22.81	28.97	17.47	29.33	0.75
Current Unearned Revenue	13.21	35.9	30.6	48.5	47.82	33.24
Other Current Liabilities	5.44	11.13	14.34	38.7	33.06	7.45
Total Current Liabilities	72.74	95.97	107.27	163.86	172.96	134.76
Long-Term Leases	404.11	417.08	438.77	221.84	413.26	22.28
Long-Term Unearned Revenue	76.54	75.18	98.78	158.06	174.77	155.99
Other Long-Term Liabilities	16.37	22.88	16.58	24.43	42.06	190.58
Total Liabilities	569.76	611.11	661.39	568.19	803.04	503.61

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Common Stock	0.01	0.01	0.01	0.01	0.19	0.16
Additional Paid-In Capital	6,699	6,657	6,555	6,386	6,136	3,805
Retained Earnings	-6,280	-6,150	-5,838	-5,291	-4,398	-2,298
Comprehensive Income & Other	0.95	1.85	-1.81	1.48	-2.63	-1.72
Total Common Equity	420.28	508.59	716.06	1,097	1,736	1,505
Minority Interest	-	-	-	-	-	62.01
Shareholders' Equity	420.28	508.59	716.06	1,097	1,736	1,567
Total Liabilities & Equity	990.05	1,120	1,377	1,665	2,539	2,071

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Total Debt	404.11	439.89	467.73	239.31	442.59	23.03
Net Cash (Debt)	-101.95	-17.27	93.84	704.76	873.2	1,527
Net Cash Growth	-	-	-86.69%	-19.29%	-42.81%	319.73%
Net Cash Per Share	-1.74	-0.31	1.81	14.50	20.79	44.90
Filing Date Shares Outstanding	67.34	58.21	54.37	50.03	51.81	43.99
Total Common Shares Outstanding	63.71	58.21	54.37	50.03	47.3	40.28
Working Capital	259.8	375.87	495.48	837.89	1,277	1,588
Book Value Per Share	6.60	8.74	13.17	21.93	36.71	37.37
Tangible Book Value	375.9	451.67	643.55	965.17	1,565	1,462
Tangible Book Value Per Share	5.90	7.76	11.84	19.29	33.09	36.30
Land	6.06	6.06	6.06	6.06	6.06	-
Buildings	49.76	49.76	48.26	47.03	-	-
Machinery	155.68	161.86	172.33	168.42	206.72	128.75
Construction In Progress	4.95	0.19	1.98	15.83	23.43	10.28
Leasehold Improvements	138.32	140.51	135.96	71.56	125.31	55.03

SEC Filings: 10-K · 10-Q